Kaveh Akhbari, DPM
Podiatry · Gilroy
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 9 carriers
- Office
- 1
Offices
1 location
Hospitals listed: El Camino Health · Hazel Hawkins Memorial Hospital · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
32 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Akhbari’s office at (408) 842-0281 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Hazel Hawkins Memorial HospitalHollister, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Hazel Hawkins Memorial Hospital
Behind the star rating — Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.1) · 409 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 43 cases | No different | Jan 2024 – Dec 2024 |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$280,578
Medicare paid this office $280,578 for 713 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 434 | $77,150 | $75 |
| Return visit (30+ min) | 199 | $27,371 | $104 |
| New patient visit (30+ min) | 249 | $20,263 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 204 | $15,250 | $35 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 18 | $13,961 | $125 |
See all 21 services
| Short return visit (20+ min) | 434 | $77,150 | $75 |
| Return visit (30+ min) | 199 | $27,371 | $104 |
| New patient visit (30+ min) | 249 | $20,263 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 204 | $15,250 | $35 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 18 | $13,961 | $125 |
| Removal of noncancer thickened skin growth, 2-4 growths | 124 | $12,865 | $74 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 22 | $11,992 | $203 |
| Removal of skin and tissue, 20.0 sq cm or less | 40 | $9,739 | $116 |
| Removal of noncancer thickened skin growth, 1 growth | 69 | $5,923 | $64 |
| Permanent removal fingernail or toenail | 33 | $5,279 | $143 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $3,672 | $50 |
| Injection into tendon or ligament | 57 | $3,658 | $49 |
| New patient visit (45+ min) | 21 | $2,664 | $127 |
| Removal of noncancer thickened skin growth, more than 4 growths | 24 | $2,642 | $71 |
| Removal of skin of fingernail or toenail | 14 | $2,462 | $154 |
| Simple separation of fingernail or toenail from nail bed, first nail | 19 | $1,873 | $99 |
| Ultrasonic guidance for needle placement | 25 | $1,428 | $53 |
| Complete ultrasound scan of joint | 26 | $1,346 | $46 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 21 | $165 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 21 | $78 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 16 | $0 | None |
Procedures Medicare counted
| Removal of nail tissue | 551 | More than 85% of doctors who do this |
| Removal of tissue | 309 | More than 94% of doctors who do this |
| Removal or shaving of skin growth | 239 | More than 91% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
713 Original Medicare patients in 2024. Average age 76 · Under 65 7% · 85 and older 19% · Women 57% · Also on Medicaid 19% · Health risk score 1.49. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 30% · Chronic kidney disease 23% · Atrial fibrillation 21% · Heart failure 19% · Depression 19% · Cancer 14% · COPD 12% · Stroke 10% · Dementia 9%.
The office billed $671,557, Medicare allowed $381,941 and paid $280,578; for 3,061 services of 62 kinds; $38,637 of it was for drugs given in the office and $241,941 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 713 | 3,061 | 76 | 1.49 | $671,557 | $280,578 |
| 2023 | 694 | 3,139 | 75 | 1.39 | $622,010 | $288,949 |
| 2022 | 639 | 3,080 | 75 | 1.41 | $542,754 | $259,351 |
| 2021 | 670 | 3,069 | 76 | 1.44 | $508,668 | $261,196 |
| 2020 | 680 | 3,126 | 76 | 1.43 | $458,013 | $222,974 |
| 2019 | 786 | 3,648 | 76 | 1.48 | $493,810 | $248,310 |
| 2018 | 744 | 3,573 | 77 | 1.68 | $444,073 | $229,104 |
| 2017 | 713 | 3,173 | 76 | 1.44 | $388,463 | $204,946 |
| 2016 | 537 | 2,176 | 76 | 1.51 | $235,533 | $128,551 |
| 2015 | 535 | 2,230 | 76 | 1.62 | $233,598 | $125,175 |
| 2014 | 491 | 2,057 | 75 | 1.49 | $235,001 | $124,220 |
| 2013 | 239 | 646 | 76 | 1.59 | $71,783 | $43,403 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Short return visit (20+ min) | 428 | $85,482 | $82 |
| New patient visit (30+ min) | 284 | $27,201 | $96 |
| Return visit (30+ min) | 177 | $24,118 | $112 |
| Removal of skin and tissue, 20.0 sq cm or less | 61 | $18,794 | $131 |
| Removal of noncancer thickened skin growth, 2-4 growths | 143 | $18,071 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 205 | $17,874 | $39 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 28 | $17,219 | $227 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 15 | $12,922 | $137 |
| Removal of noncancer thickened skin growth, 1 growth | 90 | $8,409 | $72 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $5,337 | $54 |
| Permanent removal fingernail or toenail | 26 | $4,897 | $148 |
| Removal of noncancer thickened skin growth, more than 4 growths | 31 | $3,628 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,125 | $142 |
| Removal of skin of fingernail or toenail | 19 | $2,844 | $150 |
| Injection into tendon or ligament | 26 | $1,819 | $52 |
| Simple separation of fingernail or toenail from nail bed, first nail | 15 | $1,713 | $114 |
| Short return visit (20+ min) | 11 | $1,013 | $60 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 14 | $88 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 15 | $42 | None |
2022: 20 services
| Short return visit (20+ min) | 388 | $82,544 | $82 |
| Return visit (30+ min) | 151 | $23,883 | $119 |
| Removal of skin and tissue, 20.0 sq cm or less | 47 | $22,922 | $132 |
| New patient visit (30+ min) | 228 | $21,414 | $94 |
| Removal of fingernails or toenails, 6 or more nails | 222 | $20,655 | $39 |
| Removal of noncancer thickened skin growth, 2-4 growths | 123 | $17,603 | $80 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 12 | $11,468 | $137 |
| Removal of noncancer thickened skin growth, 1 growth | 75 | $7,727 | $72 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 16 | $7,577 | $230 |
| Permanent removal fingernail or toenail | 24 | $4,270 | $142 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $3,883 | $55 |
| Removal of noncancer thickened skin growth, more than 4 growths | 18 | $3,550 | $96 |
| Injection into tendon or ligament | 39 | $2,789 | $55 |
| Simple separation of fingernail or toenail from nail bed, first nail | 18 | $1,786 | $99 |
| Short return visit (20+ min) | 15 | $1,588 | $57 |
| Complete ultrasound scan of joint | 16 | $1,019 | $60 |
| Ultrasonic guidance for needle placement | 15 | $933 | $58 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 22 | $149 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 22 | $72 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 15 | $0 | None |
2021: 23 services
| Short return visit (20+ min) | 383 | $77,635 | $84 |
| Removal of fingernails or toenails, 6 or more nails | 230 | $23,412 | $40 |
| New patient visit (30+ min) | 242 | $23,386 | $97 |
| Removal of skin and tissue, 20.0 sq cm or less | 42 | $18,486 | $133 |
| Return visit (30+ min) | 134 | $18,372 | $118 |
| Removal of noncancer thickened skin growth, 2-4 growths | 116 | $15,374 | $75 |
| Removal of noncancer thickened skin growth, 1 growth | 83 | $7,363 | $71 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 13 | $6,368 | $142 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 14 | $5,528 | $230 |
| Permanent removal fingernail or toenail | 25 | $4,866 | $147 |
| Removal of skin and tissue, 20.0 sq cm or less | 15 | $4,845 | $56 |
| Removal of skin of fingernail or toenail | 17 | $3,063 | $180 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,971 | $165 |
| Simple separation of fingernail or toenail from nail bed, first nail | 19 | $2,284 | $114 |
| New patient visit (45+ min) | 11 | $1,771 | $161 |
| Injection into tendon or ligament | 24 | $1,626 | $51 |
| Removal of noncancer thickened skin growth, more than 4 growths | 14 | $1,431 | $80 |
| Short return visit (20+ min) | 11 | $1,181 | $62 |
| Complete ultrasound scan of joint | 13 | $805 | $58 |
| Ultrasonic guidance for needle placement | 13 | $672 | $52 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 14 | $130 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 14 | $53 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 11 | $0 | None |
2020: 22 services
| Short return visit (20+ min) | 389 | $61,247 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 291 | $25,105 | $38 |
| Removal of skin and tissue, 20.0 sq cm or less | 48 | $18,905 | $120 |
| New patient visit (30+ min) | 218 | $18,585 | $85 |
| Return visit (30+ min) | 139 | $16,617 | $94 |
| Removal of noncancer thickened skin growth, 2-4 growths | 112 | $12,842 | $67 |
| Removal of noncancer thickened skin growth, 1 growth | 104 | $8,607 | $59 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $5,653 | $135 |
| Permanent removal fingernail or toenail | 32 | $5,496 | $141 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 13 | $4,514 | $215 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $3,352 | $52 |
| Simple separation of fingernail or toenail from nail bed, first nail | 24 | $2,787 | $103 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,280 | $175 |
| Injection into tendon or ligament | 34 | $1,985 | $48 |
| Complete ultrasound scan of joint | 17 | $1,535 | $73 |
| Removal of noncancer thickened skin growth, more than 4 growths | 14 | $1,220 | $55 |
| Short return visit (20+ min) | 13 | $1,159 | $45 |
| Ultrasonic guidance for needle placement | 17 | $1,094 | $52 |
| Short return visit | 12 | $495 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 21 | $134 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 33 | $82 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $21 | None |
2019: 20 services
| Short return visit (20+ min) | 448 | $74,186 | $65 |
| Removal of fingernails or toenails, 6 or more nails | 302 | $31,505 | $38 |
| New patient visit (30+ min) | 283 | $25,658 | $91 |
| Removal of skin and tissue, 20.0 sq cm or less | 61 | $22,987 | $116 |
| Return visit (30+ min) | 159 | $18,546 | $92 |
| Removal of noncancer thickened skin growth, 2-4 growths | 129 | $14,294 | $60 |
| Removal of noncancer thickened skin growth, 1 growth | 102 | $7,168 | $48 |
| Permanent removal fingernail or toenail | 37 | $6,147 | $134 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $3,461 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,160 | $166 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 11 | $3,134 | $131 |
| Injection into tendon or ligament | 44 | $2,689 | $46 |
| Simple separation of fingernail or toenail from nail bed, first nail | 26 | $2,654 | $102 |
| Removal of noncancer thickened skin growth, more than 4 growths | 18 | $1,791 | $60 |
| Complete ultrasound scan of joint | 14 | $1,297 | $86 |
| Ultrasonic guidance for needle placement | 14 | $797 | $53 |
| Short return visit (20+ min) | 12 | $615 | $44 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 33 | $223 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 44 | $96 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $20 | None |
2018: 19 services
| Short return visit (20+ min) | 427 | $65,229 | $63 |
| Removal of fingernails or toenails, 6 or more nails | 324 | $38,401 | $39 |
| New patient visit (30+ min) | 266 | $22,586 | $85 |
| Removal of skin and tissue, 20.0 sq cm or less | 44 | $16,159 | $108 |
| Return visit (30+ min) | 126 | $14,579 | $95 |
| Removal of noncancer thickened skin growth, 2-4 growths | 120 | $12,348 | $54 |
| Removal of noncancer thickened skin growth, 1 growth | 111 | $7,797 | $43 |
| Permanent removal fingernail or toenail | 23 | $3,955 | $141 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $3,679 | $53 |
| Simple separation of fingernail or toenail from nail bed, first nail | 24 | $2,643 | $102 |
| Removal of noncancer thickened skin growth, more than 4 growths | 25 | $2,628 | $60 |
| Injection into tendon or ligament | 28 | $1,874 | $48 |
| Complete ultrasound scan of joint | 11 | $1,217 | $101 |
| Short return visit (20+ min) | 13 | $984 | $45 |
| Short return visit | 18 | $744 | $39 |
| Ultrasonic guidance for needle placement | 11 | $684 | $57 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 21 | $180 | None |
| Injection, mepivacaine hydrochloride, per 10 ml | 33 | $88 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $21 | None |
2017: 22 services
| Short return visit (20+ min) | 389 | $61,094 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 291 | $33,044 | $40 |
| New patient visit (30+ min) | 304 | $26,916 | $89 |
| Removal of skin and tissue, 20.0 sq cm or less | 30 | $10,421 | $107 |
| Removal of noncancer thickened skin growth, 2-4 growths | 88 | $8,057 | $55 |
| Removal of noncancer thickened skin growth, 1 growth | 109 | $6,873 | $44 |
| Permanent removal fingernail or toenail | 29 | $5,383 | $135 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $4,224 | $50 |
| Return visit (30+ min) | 34 | $3,931 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,666 | $167 |
| Injection into tendon or ligament | 36 | $2,424 | $47 |
| New patient visit (45+ min) | 14 | $2,038 | $146 |
| Simple separation of fingernail or toenail from nail bed, first nail | 21 | $2,020 | $96 |
| Removal of noncancer thickened skin growth, more than 4 growths | 21 | $1,910 | $62 |
| Complete ultrasound scan of joint | 12 | $1,775 | $118 |
| Ultrasonic guidance for needle placement | 13 | $972 | $57 |
| Short return visit (20+ min) | 12 | $797 | $44 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $307 | $26 |
| Trimming of dystrophic nails, any number | 12 | $169 | $14 |
| Injection, mepivacaine hydrochloride, per 10 ml | 38 | $124 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 14 | $94 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $63 | None |
2016: 15 services
| Short return visit (20+ min) | 293 | $43,627 | $60 |
| Removal of fingernails or toenails, 6 or more nails | 192 | $20,179 | $38 |
| New patient visit (30+ min) | 208 | $16,358 | $79 |
| Removal of noncancer thickened skin growth, 2-4 growths | 75 | $7,693 | $52 |
| Removal of noncancer thickened skin growth, 1 growth | 83 | $4,804 | $42 |
| Permanent removal fingernail or toenail | 18 | $3,503 | $159 |
| Return visit (30+ min) | 22 | $2,423 | $90 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $2,258 | $53 |
| Removal of noncancer thickened skin growth, more than 4 growths | 14 | $1,146 | $55 |
| Simple separation of fingernail or toenail from nail bed, first nail | 13 | $1,107 | $85 |
| Removal of fingernails or toenails, 1-5 nails | 39 | $1,062 | $25 |
| Injection into tendon or ligament | 15 | $934 | $52 |
| Trimming of dystrophic nails, any number | 54 | $868 | $15 |
| Injection, mepivacaine hydrochloride, per 10 ml | 17 | $37 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $18 | None |
2015: 13 services
| Short return visit (20+ min) | 268 | $36,159 | $61 |
| New patient visit (30+ min) | 233 | $19,494 | $84 |
| Removal of noncancer thickened skin growth, 2-4 growths | 76 | $8,165 | $47 |
| Removal of fingernails or toenails, 1-5 nails | 132 | $7,871 | $28 |
| Trimming of dystrophic nails, any number | 153 | $5,769 | $18 |
| Permanent removal fingernail or toenail | 24 | $5,557 | $179 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $5,525 | $53 |
| Removal of noncancer thickened skin growth, 1 growth | 75 | $4,357 | $41 |
| Removal of fingernails or toenails, 6 or more nails | 95 | $4,106 | $36 |
| Return visit (30+ min) | 23 | $2,462 | $95 |
| Simple separation of fingernail or toenail from nail bed, first nail | 16 | $1,805 | $90 |
| Injection into tendon or ligament | 13 | $865 | $54 |
| Injection, mepivacaine hydrochloride, per 10 ml | 14 | $29 | None |
2014: 14 services
| Short return visit (20+ min) | 267 | $32,685 | $61 |
| New patient visit (30+ min) | 196 | $16,021 | $82 |
| Removal of noncancer thickened skin growth, 2-4 growths | 79 | $8,599 | $54 |
| Removal of skin and tissue, 20.0 sq cm or less | 21 | $6,426 | $52 |
| Removal of fingernails or toenails, 1-5 nails | 110 | $6,312 | $27 |
| Removal of noncancer thickened skin growth, 1 growth | 76 | $4,317 | $40 |
| Removal of fingernails or toenails, 6 or more nails | 81 | $4,302 | $37 |
| Trimming of dystrophic nails, any number | 114 | $4,234 | $18 |
| Permanent removal fingernail or toenail | 11 | $2,446 | $188 |
| Return visit (30+ min) | 26 | $2,381 | $85 |
| Simple separation of fingernail or toenail from nail bed, first nail | 22 | $2,105 | $88 |
| Short return visit (20+ min) | 16 | $1,228 | $42 |
| Injection into tendon or ligament | 12 | $834 | $52 |
| Injection, mepivacaine hydrochloride, per 10 ml | 12 | $29 | None |
2013: 10 services
| Short return visit (20+ min) | 114 | $13,209 | $67 |
| New patient visit (30+ min) | 62 | $5,861 | $95 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $3,730 | $54 |
| Removal of fingernails or toenails, 6 or more nails | 47 | $2,474 | $42 |
| Removal of noncancer thickened skin growth, 2-4 growths | 27 | $2,015 | $58 |
| Removal of noncancer thickened skin growth, 1 growth | 28 | $1,480 | $48 |
| Return visit (30+ min) | 13 | $1,384 | $99 |
| Short return visit (20+ min) | 13 | $1,227 | $44 |
| Trimming of dystrophic nails, any number | 39 | $1,091 | $22 |
| Removal of fingernails or toenails, 1-5 nails | 19 | $659 | $31 |
Medicaid work
$378 in 2024
Medicaid paid $378 for 55 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 55 | $378 |
| 2024 | 55 | 1 | 13 | $378 |
| 2023 | 239 | 1 | 27 | $1,327 |
| 2022 | 227 | 2 | 26 | $69 |
| 2021 | 231 | 1 | 26 | $89 |
| 2020 | 180 | 2 | 21 | $65 |
| 2019 | 90 | 1 | 15 | $77 |
| 2018 | 15 | 1 | 14 | $0 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 239 | $1,327 |
2022
| Short return visit (20+ min) | 214 | $69 |
| Return visit (30+ min) | 13 | $0 |
2021
| Short return visit (20+ min) | 231 | $89 |
2020
| Short return visit (20+ min) | 168 | $65 |
| New patient visit (30+ min) | 12 | $0 |
2019
| Short return visit (20+ min) | 90 | $77 |
2018
| Short return visit (20+ min) | 15 | $0 |
Drugs they prescribed that Part D paid
$67,527
Pharmacies billed $67,527 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (27 of 718) in 2024. At or below the middle of the specialty; the typical podiatry clinician is at 5%.
642 generic and 76 brand-name prescriptions · $67,527 in drug cost · 103 antibiotic prescriptions to 62 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jublia | 57 | $55,166 | $968 |
| Santyl | 15 | $4,612 | $307 |
| Ciclopirox | 85 | $1,794 | $21 |
| Terbinafine | 125 | $1,260 | $10 |
| Mupirocin | 135 | $875 | $6 |
See all 15 drugs
| Jublia | 57 | $55,166 | $968 |
| Santyl | 15 | $4,612 | $307 |
| Ciclopirox | 85 | $1,794 | $21 |
| Terbinafine | 125 | $1,260 | $10 |
| Mupirocin | 135 | $875 | $6 |
| Clotrimazole | 23 | $372 | $16 |
| Ammonium Lactate | 24 | $347 | $14 |
| Oxycodone-Acetaminophen | 25 | $226 | $9 |
| Clindamycin | 13 | $137 | $11 |
| Meloxicam | 31 | $126 | $4 |
| Gabapentin | 26 | $120 | $5 |
| Cephalexin | 26 | $97 | $4 |
| Amoxicillin-Clavulanate Potass | 18 | $95 | $5 |
| Sulfamethoxazole-Trimethoprim | 20 | $70 | $3 |
| Ciprofloxacin | 23 | $68 | $3 |
Year by year
| 2024 | 718 | 304 | 4% (27) | 11% | $67,527 |
| 2023 | 614 | 270 | 4% (26) | 7% | $48,569 |
| 2022 | 652 | 257 | 3% (19) | 6% | $32,962 |
| 2021 | 713 | 289 | 3% (23) | 5% | $29,815 |
| 2020 | 915 | 339 | 5% (42) | 4% | $25,427 |
| 2019 | 858 | 354 | 3% (26) | 6% | $24,984 |
| 2018 | 552 | 237 | 6% (31) | 14% | $18,543 |
| 2017 | 486 | 211 | 5% (24) | 12% | $27,930 |
| 2016 | 411 | 185 | 3% (11) | 11% | $24,171 |
| 2015 | 378 | 165 | 6% (22) | 9% | $18,880 |
| 2014 | 303 | 156 | 8% (24) | None | $9,867 |
| 2013 | 80 | 50 | 15% (12) | 25% | $3,681 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Jublia | 28 | $32,520 | $1,161 |
| Santyl | 16 | $5,111 | $319 |
| Ciclopirox | 86 | $3,228 | $38 |
| Mupirocin | 181 | $1,890 | $10 |
| Terbinafine | 92 | $1,054 | $11 |
| Clotrimazole | 28 | $810 | $29 |
| Ciprofloxacin | 19 | $244 | $13 |
| Amoxicillin-Clavulanate Potass | 16 | $202 | $13 |
| Gabapentin | 14 | $135 | $10 |
| Sulfamethoxazole-Trimethoprim | 15 | $135 | $9 |
| Cephalexin | 19 | $81 | $4 |
| Meloxicam | 15 | $44 | $3 |
2022: 13 drugs
| Jublia | 20 | $16,867 | $843 |
| Santyl | 18 | $5,272 | $293 |
| Ciclopirox | 127 | $4,005 | $32 |
| Mupirocin | 152 | $1,760 | $12 |
| Terbinafine | 85 | $953 | $11 |
| Ammonium Lactate | 24 | $565 | $24 |
| Clotrimazole | 17 | $465 | $27 |
| Gabapentin | 15 | $334 | $22 |
| Amoxicillin-Clavulanate Potass | 19 | $262 | $14 |
| Ciprofloxacin | 28 | $219 | $8 |
| Cephalexin | 28 | $152 | $5 |
| Naproxen | 19 | $120 | $6 |
| Meloxicam | 18 | $46 | $3 |
2021: 16 drugs
| Jublia | 11 | $10,033 | $912 |
| Santyl | 22 | $7,318 | $333 |
| Ciclopirox | 169 | $5,299 | $31 |
| Mupirocin | 143 | $1,475 | $10 |
| Clotrimazole | 33 | $1,291 | $39 |
| Diclofenac | 35 | $819 | $23 |
| Terbinafine | 50 | $543 | $11 |
| Clotrimazole-Betamethasone | 11 | $445 | $40 |
| Amoxicillin-Clavulanate Potass | 18 | $422 | $23 |
| Ciprofloxacin | 33 | $313 | $9 |
| Clindamycin | 22 | $239 | $11 |
| Cephalexin | 37 | $175 | $5 |
| Naproxen | 19 | $126 | $7 |
| Oxycodone-Acetaminophen | 12 | $106 | $9 |
| Meloxicam | 24 | $103 | $4 |
| Gabapentin | 16 | $78 | $5 |
2020: 14 drugs
| Ciclopirox | 228 | $6,618 | $29 |
| Santyl | 20 | $5,238 | $262 |
| Diclofenac | 147 | $3,804 | $26 |
| Clotrimazole | 80 | $2,208 | $28 |
| Mupirocin | 145 | $1,281 | $9 |
| Terbinafine | 64 | $514 | $8 |
| Oxycodone-Acetaminophen | 25 | $283 | $11 |
| Gabapentin | 37 | $238 | $6 |
| Clindamycin | 16 | $186 | $12 |
| Cephalexin | 26 | $110 | $4 |
| Ciprofloxacin | 21 | $106 | $5 |
| Meloxicam | 24 | $72 | $3 |
| Naproxen | 12 | $66 | $5 |
| Tramadol | 12 | $40 | $3 |
2019: 13 drugs
| Ciclopirox | 258 | $6,921 | $27 |
| Santyl | 21 | $5,115 | $244 |
| Diclofenac | 112 | $3,332 | $30 |
| Clotrimazole | 47 | $1,611 | $34 |
| Mupirocin | 139 | $1,391 | $10 |
| Voltaren | 14 | $770 | $55 |
| Gabapentin | 52 | $471 | $9 |
| Terbinafine | 41 | $438 | $11 |
| Clindamycin | 14 | $242 | $17 |
| Cephalexin | 39 | $170 | $4 |
| Ciprofloxacin | 12 | $169 | $14 |
| Oxycodone-Acetaminophen | 16 | $112 | $7 |
| Meloxicam | 19 | $79 | $4 |
2018: 11 drugs
| Ciclopirox | 180 | $5,218 | $29 |
| Voltaren | 32 | $1,761 | $55 |
| Diclofenac | 40 | $1,271 | $32 |
| Mupirocin | 83 | $964 | $12 |
| Clotrimazole | 19 | $761 | $40 |
| Terbinafine | 27 | $275 | $10 |
| Oxycodone-Acetaminophen | 20 | $237 | $12 |
| Gabapentin | 28 | $154 | $5 |
| Ciprofloxacin | 14 | $91 | $7 |
| Cephalexin | 16 | $82 | $5 |
| Meloxicam | 14 | $37 | $3 |
2017: 11 drugs
| Santyl | 12 | $5,263 | $439 |
| Ciclopirox | 159 | $4,753 | $30 |
| Econazole Nitrate | 12 | $2,704 | $225 |
| Voltaren | 19 | $989 | $52 |
| Diclofenac | 22 | $752 | $34 |
| Mupirocin | 70 | $667 | $10 |
| Ciprofloxacin | 22 | $177 | $8 |
| Terbinafine | 22 | $154 | $7 |
| Cephalexin | 24 | $96 | $4 |
| Meloxicam | 28 | $95 | $3 |
| Oxycodone-Acetaminophen | 13 | $73 | $6 |
2016: 8 drugs
| Ciclopirox | 154 | $4,723 | $31 |
| Econazole Nitrate | 15 | $3,004 | $200 |
| Voltaren | 23 | $1,131 | $49 |
| Mupirocin | 64 | $576 | $9 |
| Diclofenac | 14 | $575 | $41 |
| Cephalexin | 22 | $145 | $7 |
| Terbinafine | 18 | $142 | $8 |
| Meloxicam | 13 | $60 | $5 |
2015: 8 drugs
| Ciclopirox | 145 | $4,780 | $33 |
| Econazole Nitrate | 24 | $4,234 | $176 |
| Santyl | 11 | $2,138 | $194 |
| Mupirocin | 51 | $870 | $17 |
| Voltaren | 18 | $847 | $47 |
| Cephalexin | 20 | $89 | $4 |
| Ciprofloxacin | 12 | $86 | $7 |
| Meloxicam | 18 | $48 | $3 |
2014: 7 drugs
| Ciclopirox | 119 | $4,005 | $34 |
| Santyl | 11 | $2,080 | $189 |
| Econazole Nitrate | 18 | $983 | $55 |
| Voltaren | 15 | $798 | $53 |
| Mupirocin | 36 | $443 | $12 |
| Cephalexin | 22 | $118 | $5 |
| Meloxicam | 13 | $49 | $4 |
2013: 1 drug
| Ciclopirox | 22 | $1,091 | $50 |
Money from drug and device companies
$490 in 2025
| 2025 | 5 | 31 | None | $490 |
| 2024 | 6 | 52 | None | $1,127 |
| 2023 | 5 | 38 | None | $1,010 |
| 2022 | 5 | 39 | None | $1,032 |
| 2021 | 5 | 43 | None | $1,088 |
| 2020 | 2 | 37 | None | $694 |
| 2019 | 8 | 69 | None | $1,276 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ortho Dermatologics a division of Bausch Health US | Jublia | $243 | 24 payments
|
| Paragon 28 | Hammertube Sterile Implant Kits | $112 | 1 payment
|
| Stryker | Flexband | $98 | 4 payments
|
| ConvaTec | Aquacel Ag+ | $19 | 1 payment
|
| Globus Medical | Senza | $18 | 1 payment
|
See all 31 published payments
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-22 | Jublia | $6 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-22 | Jublia | $8 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-12-09 | Jublia | $7 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-11-24 | Jublia | $11 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-11-17 | Jublia | $12 |
| Globus Medical | Meals · 2025-11-11 | Senza | $18 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-10-20 | Jublia | $10 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-22 | Jublia | $12 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-22 | Jublia | $10 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-16 | Jublia | $11 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-09-16 | Jublia | $9 |
| Stryker | Meals · 2025-09-09 | Augment Injectable | $24 |
| Stryker | Meals · 2025-08-28 | Prostep Mica | $18 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-08-20 | Jublia | $9 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-08-20 | Jublia | $10 |
| Stryker | Meals · 2025-08-14 | Flexband | $29 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-28 | Jublia | $10 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-14 | Jublia | $10 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-07-08 | Jublia | $10 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-30 | Jublia | $18 |
| Paragon 28 | Meals · 2025-06-26 | Hammertube Sterile Implant Kits | $112 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-06-03 | Jublia | $8 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-05-20 | Jublia | $13 |
| Stryker | Meals · 2025-05-01 | Pro-Toe | $27 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-04-28 | Jublia | $8 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-04-14 | Jublia | $11 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-04-09 | Jublia | $9 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-03-20 | Jublia | $11 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-02-28 | Jublia | $9 |
| Ortho Dermatologics a division of Bausch Health US | Meals · 2025-02-18 | Jublia | $10 |
| ConvaTec | Meals · 2025-02-12 | Aquacel Ag+ | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,127
| Biotissue Holdings | None | $516 | 19 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $207 | 22 payments
|
| Stryker | Actishield | $181 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $154 | 8 payments
|
| Organogenesis | None | $37 | 1 payment
|
| Evolution Surgical | None | $31 | 1 payment
|
2023: $1,010
| Biotissue Holdings | Neox | $493 | 15 payments
|
| Treace Medical Concepts | Lapiplasty System | $264 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $158 | 18 payments
|
| Smith+Nephew | Collagenase Santyl | $55 | 2 payments
|
| Organogenesis | Puraply | $39 | 1 payment
|
2022: $1,032
| Smith+Nephew | Grafix Pl | $944 | 35 payments
|
| Stryker | Lmh | $28 | 1 payment
|
| Ethicon US | Surgicel Nu-Knit | $24 | 1 payment
|
| Bioventus | None | $20 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $15 | 1 payment
|
2021: $1,088
| Smith+Nephew | Grafix Pl | $795 | 36 payments
|
| Treace Medical Concepts | Lapiplasty System | $158 | 1 payment
|
| Bard Peripheral Vascular | Lutonix | $57 | 3 payments
|
| Organogenesis | Puraply Antimicrobial | $43 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $35 | 2 payments
|
2020: $694
| Smith+Nephew | Grafix Pl | $671 | 36 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $23 | 1 payment
|
2019: $1,276
| Smith+Nephew | Stravix | $906 | 51 payments
|
| Osiris Therapeutics | Stravix | $227 | 11 payments
|
| Kci USA | Activac | $30 | 1 payment
|
| Paragon 28 | None | $30 | 1 payment
|
| Arthrosurface | Hemicap Mtp Resurfacing | $28 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $23 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Bryhali | $18 | 1 payment
|
| Zyla Life Sciences | Sprix | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144541764
- Licence
- CA E5062
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Student in a training program (390200000X)
- Mailing address
- 80 West 5th Street, Gilroy, CA, 95020
- NPI first listed
- 2010-06-17
- NPI last updated
- 2014-09-03
This is when the NPI record was last certified, not a medical board exam.